Showing results (21-30 of 497) with videos related to
Sort By:
Pageof 50
Antimicrobial Agents and Chemotherapy|September 19, 2000
In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalisP A Warn, J Morrissey, C B Moore, et al.Journal of Clinical Microbiology|April 1, 1997
Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strainsS Nho, M J Anderson, C B Moore, et al.Mycoses|November 1, 1996
Characterization of Aspergillus isolates by pyrolysis mass spectrometryD Law, P R Sisson, R Freeman, et al.The Journal of Antimicrobial Chemotherapy|March 7, 2007
Flucytosine therapeutic monitoring: 15 years experience from the UKA C Pasqualotto, S J Howard, C B Moore, et al.The Journal of Antimicrobial Chemotherapy|August 6, 2002
In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus sppJ Mosquera, A Sharp, C B Moore, et al.The British Journal of Dermatology|June 1, 1997
Atypical eumycetoma caused by Phialophora parasitica successfully treated with itraconazole and flucytosineS V Hood, C B Moore, J S Cheesbrough, et al.Journal of Clinical Microbiology|June 28, 2001
Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcomeC Wenisch, C B Moore, R Krause, et al.Antimicrobial Agents and Chemotherapy|April 17, 2001
Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivoJ Mosquera, P A Warn, J Morrissey, et al.The Journal of Infection|November 20, 1998
Variation in morphotype, karyotype and DNA type of fluconazole resistant Candida albicans from an AIDS patientT Takasuka, G G Baily, M Birch, et al.Pageof 50